The disease burden of respiratory syncytial virus in Infants

PURPOSE OF REVIEW: To describe the current global burden of respiratory syncytial virus (RSV) in infants and its implications for morbidity, health resources and economic costs. RECENT FINDINGS: New prophylactic therapies are on the horizon for RSV in the form of long-acting monoclonal antibodies su...

Descripción completa

Detalles Bibliográficos
Autores principales: Munro, Alasdair P.S., Martinón-Torres, Federico, Drysdale, Simon B., Faust, Saul N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
PAEDIATRIC AND NEONATAL INFECTIONS: Edited by Scott H. James
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487373/
https://www.ncbi.nlm.nih.gov/pubmed/37610444
http://dx.doi.org/10.1097/QCO.0000000000000952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487373/
https://www.ncbi.nlm.nih.gov/pubmed/37610444
http://dx.doi.org/10.1097/QCO.0000000000000952

Ejemplares similares